Take Solutions strides ahead in the pharma sector
Published on Tue, Jul 22 at 16:28 , Updated at Tue, Jul 22 at 16:57
Source : Moneycontrol.com
| ads by google |
TAKE Solutions announced today that its worldwide business in regulatory document management and electronic submissions software arena is making quick inroads in the Indian market. The addition of these new clients to TAKE Solutions’ globally renowned PharmaReady suite, makes this product very well entrenched in the Indian market. Amongst others, key customers in India are Ajanta Pharma, Alembic Ltd., Alkem, Dabur, Emcure Pharmaceuticals, Marksans Pharma and Serum Institute. With esubmissions becoming mandatory in many of the countries in the West, more and more Pharma companies in India are realizing the need to update their processes and procedures to the eSubmissions platform. With a 100% implementation and submissions success rate, PharmaReady is being put to constant use by customers in · 12 countries · across 4 continents
The PharmaReady suite of software distinguishes itself from the marketplace by being relevant to a wide range of global life sciences customers and prospects. This includes branded and generic bio-pharmaceutical companies in various stages of their research and application process as they seek approval from global regulatory agencies. This success of the ParmaReady Suite can be attributed to 3 key factors:
Unlike many of its competitors, TAKE Solutions has near shore support centers located in Chennai, India for the Asia Pacific customer base that makes it very convenient for users located in this part of the world. TAKE’s offices in North America serve as the support centers for the North American and European customer base. Talking about the company’s growth Mr. L. Ramesh, Vice President – Sales: Life Sciences – Asia Pacific & Emerging Markets, TAKE Solutions Ltd. said, “We continuously strive to add value and bring the significance and relevance of global regulatory standards to the life sciences customer base, acting as a key liaison and a thought leader in this space”. Sourced From: Adfactors Public Relations Pvt Ltd |
Messages on News Now
Other comments
India Inc hails NSG waiver, sees $40 bn p
India Inc hails NSG waiver, sees $40 bn potential----------------------NEW DELHI: As many as 400 Indian and foreign...
in News Now - latikav at 07-Sep-08 09:23
India Inc hails NSG waiver, sees $40 bn potential
A matter for debate..... There is no way that India can conduct nuclear tests now,the Indian Government has give...
in News Now - zoombusiness at 06-Sep-08 11:51
Rate this article
Latest Market Commentary
05-09 Mkts butchered on bad global cues; RIL, Infy, Bharti drag
04-09 Mkts end lower on profit booking; oil, metal, telecom drag
Udayan's Comments
06-09 NSG waiver to give a sentiment boost to mkts
05-09 Mkts catch global chill; NSG outcome key
F&O Markets
05-09 F&O turnover stands at Rs 37,000 cr
05-09 FIIs net sell Rs 1337 cr in Nifty futures
Market Interview Transcripts
05-09 Focus on Zenotach Labs now, post Ranbaxy open offer
04-09 Go for differential rights
CNBC TV18 Research Reports
06-09 Want to scuba dive: Go Bangalore!
06-09 Hyderabad's religious cuisine gets costly due to inflation
Brokerage Reports
05-09 Rashtriya Chemicals an underperformer: HDFC Securities
Chat
SP Tulsian
Investment Advisor ,
(08 Sep- 13:00hrs)
NSG & its impact on markets
Poll
Newsletter
Keep in touch with News day & night. Subscribe to:
Mobile Services
Get news on the move SMS to 52622
- SMS M for Market News
- SMS B for Latest Business News
- SMS S (stock name) for latest news




Offline





